CoChat

Postpartum Body Mass Index Change Is Associated with Incident Dysglycemia in Women with a History of Gestational Diabetes Mellitus: A Prospective Cohort Study

Open access

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 17 of the 26 sources its claims cite were checked for support.

Abstract

Prospective cohort study evaluating postpartum BMI change and incident dysglycemia in women with prior gestational diabetes.

Overview

CoChat Summary

TL;DR

In a single-center prospective cohort of 205 Japanese women with gestational diabetes mellitus (GDM), greater postpartum BMI increase independently predicted incident impaired fasting glucose/impaired glucose tolerance (IFG/IGT) but not type 2 diabetes mellitus (T2DM) or dyslipidemia after adjustment. Postpartum BMI change may help identify women at higher risk of dysglycemia, though the observational design precludes causal inference.

Key findings

  • Over a median follow-up of 3.6 years, 42.4% developed IFG/IGT, 6.3% developed T2DM, and 35.6% developed dyslipidemia; Kaplan–Meier estimated cumulative incidence at 6 years postpartum was 57.1% for IFG/IGT and approximately 50% for dyslipidemia, while 5-year T2DM incidence was 10.3%.
  • Postpartum BMI ≥25 kg/m² was associated with higher cumulative incidence of IFG/IGT (log-rank p = 0.005), T2DM (p = 0.010), and dyslipidemia (p < 0.001) compared with BMI <25 kg/m².
  • In multivariable Cox analysis, greater BMI change during follow-up remained independently associated with incident IFG/IGT (HR 1.15, 95% CI 1.04–1.27; p = 0.006); each 1-unit BMI increase was associated with approximately 15% higher risk, and a +3 kg/m² increase with approximately 50% higher risk of prediabetes. Higher pregnancy OGTT 2 h glucose and higher postpartum OGTT 1 h glucose were also independently associated with IFG/IGT.
  • For T2DM, no clear independent predictor was identified after adjustment (complete-case n = 195; 12 events; previous GDM borderline HR 3.79, 95% CI 1.00–14.38; p = 0.050). For dyslipidemia, BMI change was not independently associated after adjustment (HR 1.05, 95% CI 0.94–1.17; p = 0.418), whereas higher pre-pregnancy BMI and multiparity remained independently associated.

Methods

  • Single-center prospective cohort (GDM-PPAP) at Hirosaki University Hospital, Japan; 260 women with singleton GDM pregnancies were diagnosed, 243 underwent postpartum 75 g OGTT, 3 were excluded for overt diabetes, 35 were lost to follow-up, leaving 205 women in the final analysis. Recruitment was January 2014–December 2021, with follow-up until December 2024.
  • All participants underwent a 75 g OGTT at 6–12 weeks postpartum. Outcomes were incident IFG/IGT, T2DM, and dyslipidemia. Postpartum BMI change was defined as BMI at the 1-month postpartum visit minus BMI at the last follow-up visit; if an intervening pregnancy occurred, change was calculated from pre-pregnancy BMI before the new pregnancy to BMI at last follow-up. Participants were also categorized into tertiles of postpartum BMI change.
  • Kaplan–Meier methods and log-rank tests estimated cumulative incidence; Cox proportional hazards models estimated hazard ratios. Variables with p < 0.05 in univariable analyses were entered into multivariable models; complete-case analysis was used, and analyses were performed with SPSS version 25.

Limitations

  • The paper states that breastfeeding practices were not systematically collected; lifestyle factors such as diet, physical activity, and pharmacological prevention were not systematically measured; 33 of 205 participants (16.1%) had a subsequent pregnancy, so informative censoring and exposure contamination cannot be completely excluded, and the interconception interval was not analyzed; T2DM events were limited, reducing statistical power; and the single tertiary center with only Japanese women may limit generalizability.
  • The paper also states that the observational design means causal inferences cannot be made, and that the T2DM multivariable findings should be considered exploratory.
  • Evident from the text: complete-case analysis led to varying analyzed sample sizes across outcomes (e.g., n = 187 for IFG/IGT, n = 195 for T2DM, n = 193 for dyslipidemia), which may introduce selection bias; no formal a priori sample size calculation was performed, although a post hoc power estimate was described.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jcm15072634

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flow diagram of participant selection in the GDM-PPAP study. Among 260 women diagnosed with GDM, 243 underwent a postpartum OGTT within 12 weeks. After excluding three women diagnosed with overt diabetes and 35 lost to follow-up, 205 women were included in the final analysis.
Figure 1 Flow diagram of participant selection in the GDM-PPAP study. Among 260 women diagnosed with GDM, 243 underwent a postpartum OGTT within 12 weeks. After excluding three women diagnosed with overt diabetes and 35 lost to follow-up, 205 women were included in the final analysis.CC BY · PubMed Central
Figure 2 Kaplan–Meier curves showing the cumulative incidence of metabolic outcomes during the 10-year observation period among women with a history of GDM. (a) IFG or IGT; (b) T2DM; (c) dyslipidemia. Censoring is indicated by tick marks on the curves. Abbreviations: GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus.
Figure 2 Kaplan–Meier curves showing the cumulative incidence of metabolic outcomes during the 10-year observation period among women with a history of GDM. (a) IFG or IGT; (b) T2DM; (c) dyslipidemia. Censoring is indicated by tick marks on the curves. Abbreviations: GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus.CC BY · PubMed Central
Figure 3 Kaplan–Meier curves showing the cumulative incidence of metabolic outcomes during the 10-year observation period among women with a history of GDM, stratified by postpartum BMI (<25 kg/m2 vs. ≥25 kg/m2). (a) Impaired glucose tolerance (IFG/IGT), with significantly higher incidence in women with postpartum BMI ≥ 25 kg/m2 (log-rank test, p = 0.005); (b) T2DM, with significantly higher incidence in women with postpartum BMI ≥ 25 kg/m2 (log-rank test, p = 0.01); (c) dyslipidemia, with a significantly higher incidence in women with postpartum BMI ≥ 25 kg/m2 (log-rank p < 0.001). Abbreviations: GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus; BMI, body mass index; p, probability value; log-rank test, Mantel–Cox test.
Figure 3 Kaplan–Meier curves showing the cumulative incidence of metabolic outcomes during the 10-year observation period among women with a history of GDM, stratified by postpartum BMI (<25 kg/m2 vs. ≥25 kg/m2). (a) Impaired glucose tolerance (IFG/IGT), with significantly higher incidence in women with postpartum BMI ≥ 25 kg/m2 (log-rank test, p = 0.005); (b) T2DM, with significantly higher incidence in women with postpartum BMI ≥ 25 kg/m2 (log-rank test, p = 0.01); (c) dyslipidemia, with a significantly higher incidence in women with postpartum BMI ≥ 25 kg/m2 (log-rank p < 0.001). Abbreviations: GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus; BMI, body mass index; p, probability value; log-rank test, Mantel–Cox test.CC BY · PubMed Central
Figure 4 Kaplan–Meier curves showing the cumulative incidence of metabolic outcomes during the 10-year observation period among women with a history of GDM, stratified by postpartum BMI change (tertiles). (a) IFG or IGT, with a significantly higher cumulative incidence in Group 3 (highest tertile of BMI change) than in Group 1 (lowest tertile) (log-rank test, p = 0.004); (b) T2DM, with no significant differences observed among the three groups; (c) dyslipidemia, with significantly higher cumulative incidence in Group 2 and Group 3 than in Group 1 (log-rank p < 0.001). Abbreviations: GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus; BMI, body mass index; p, probability value; log-rank test, Mantel–Cox test.
Figure 4 Kaplan–Meier curves showing the cumulative incidence of metabolic outcomes during the 10-year observation period among women with a history of GDM, stratified by postpartum BMI change (tertiles). (a) IFG or IGT, with a significantly higher cumulative incidence in Group 3 (highest tertile of BMI change) than in Group 1 (lowest tertile) (log-rank test, p = 0.004); (b) T2DM, with no significant differences observed among the three groups; (c) dyslipidemia, with significantly higher cumulative incidence in Group 2 and Group 3 than in Group 1 (log-rank p < 0.001). Abbreviations: GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus; BMI, body mass index; p, probability value; log-rank test, Mantel–Cox test.CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 1 Not valid · 7 Not checked · 84 Own results and interpretations

51 more claims

Create a free account to see all 105 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 37
  • It may state two separate claims as one. 21

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 28 references

Metadata

Authors
Tsushima, R., Ito, A., Oishi, M., Ishihara, K., Iino, K., Tanaka, K., & Yokoyama, Y.
Affiliations
  • Hirosaki University (JP)
  • Odate Municipal General Hospital (JP)
  • Hirosaki General Medical Center, Hirosaki 036-8562, Aomori, Japan
Corresponding author
Ito, Asami
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2026-03-30
Volume
15
Issue
7
Pages
2634
ISSN
2077-0383 (ISSN-L)
OpenAlex
W7143508040
Cited by
0
References
28
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Hirosaki University
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
gestational diabetes mellitus, postpartum weight change, body mass index, dysglycemia, type 2 diabetes, prediabetes, impaired fasting glucose, impaired glucose tolerance, dyslipidemia, pre-pregnancy body mass index, multiparity, long-term metabolic outcomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Postpartum Body Mass Index Change Is Associated with Incident Dysglycemia in Women with a History of Gestational Diabetes Mellitus: A Prospective Cohort Study. https://app.cochat.ai/papers/10.3390/jcm15072634
The paper
Tsushima, R., Ito, A., Oishi, M., Ishihara, K., Iino, K., Tanaka, K., & Yokoyama, Y. (2026). Postpartum Body Mass Index Change Is Associated with Incident Dysglycemia in Women with a History of Gestational Diabetes Mellitus: A Prospective Cohort Study. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15072634

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.